Cause-specific survival advantage shown for hormone therapy for diploid prostate tumors.
Zincke
H
H
D000728:Androgens / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004273:DNA, Neoplasm / Q000235:genetics; D004171:Diploidy; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery; D015996:Survival Rate; D013997:Time Factors
D000728:Androgens; D004273:DNA, Neoplasm